Amgen Inc (NASDAQ:AMGN)

196.94
Delayed Data
As of Sep 20
 +1.29 / +0.66%
Today’s Change
166.30
Today|||52-Week Range
211.90
+1.17%
Year-to-Date

Today’s Trading

Previous close195.65
Today’s open196.00
Day’s range195.75 - 199.32
Volume6,907,346
Average volume (3 months)3,035,875
Market cap$118.9B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+368.59%
Earnings growth (this year)-0.70%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+4.32%
P/E ratio15.6
Price/Sales5.45
Price/Book9.99

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.46+0.70%
ILMNIllumina Inc+4.37+1.43%
BIIBBiogen+3.17+1.35%
EXASExact Sciences Corp+0.57+0.55%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateOctober 31, 2019
EPS forecast (this quarter)$3.49
Annual revenue (last year)$23.8B
Annual profit (last year)$8.4B
Net profit margin35.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts